{"id":"https://openalex.org/W4282966367","doi":"https://doi.org/10.1158/1538-7445.am2022-2636","title":"Abstract 2636: Targeting Autotaxin to suppress stromal signaling in the tumor microenvironment to improve outcome to therapy in fibrotic tumor types","display_name":"Abstract 2636: Targeting Autotaxin to suppress stromal signaling in the tumor microenvironment to improve outcome to therapy in fibrotic tumor types","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282966367","doi":"https://doi.org/10.1158/1538-7445.am2022-2636"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-2636","doi":"https://doi.org/10.1158/1538-7445.am2022-2636","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2636","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076391983","display_name":"Zo\u00eb Johnson","orcid":"https://orcid.org/0000-0002-4120-2579","observed_orcids":["https://orcid.org/0000-0002-4120-2579"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Zoe Johnson","raw_affiliation_strings":["1iOnctura SA, Geneva, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1iOnctura SA, Geneva, Switzerland;","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037222040","display_name":"Marcel A. Deken","orcid":"https://orcid.org/0009-0005-7324-7631","observed_orcids":["https://orcid.org/0009-0005-7324-7631"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marcel Deken","raw_affiliation_strings":["1iOnctura SA, Geneva, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1iOnctura SA, Geneva, Switzerland;","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014353501","display_name":"Ragini Medhi","orcid":"https://orcid.org/0000-0002-2780-0708","observed_orcids":["https://orcid.org/0000-0002-2780-0708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ragini Medhi","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060985002","display_name":"Lauren Z. Maggs","orcid":"https://orcid.org/0000-0002-8053-2749","observed_orcids":["https://orcid.org/0000-0002-8053-2749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lauren Maggs","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111648867","display_name":"Alan M. Carruthers","orcid":"https://orcid.org/0009-0008-2701-672X","observed_orcids":["https://orcid.org/0009-0008-2701-672X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Carruthers","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038718794","display_name":"Anne Cheasty","orcid":"https://orcid.org/0000-0001-7868-1027","observed_orcids":["https://orcid.org/0000-0001-7868-1027"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Cheasty","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037389511","display_name":"Alessia Tagliavini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alessia Tagliavini","raw_affiliation_strings":["3Evotec, Verona, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Evotec, Verona, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045869950","display_name":"Andrea Nizzardo","orcid":"https://orcid.org/0000-0002-6703-6898","observed_orcids":["https://orcid.org/0000-0002-6703-6898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Nizzardo","raw_affiliation_strings":["3Evotec, Verona, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Evotec, Verona, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075801611","display_name":"Marco Pergher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marco Pergher","raw_affiliation_strings":["3Evotec, Verona, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Evotec, Verona, Italy;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073306162","display_name":"Karolina Niewola\u2010Staszkowska","orcid":"https://orcid.org/0000-0001-7225-3419","observed_orcids":["https://orcid.org/0000-0001-7225-3419"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Karolina Niewola","raw_affiliation_strings":["1iOnctura SA, Geneva, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1iOnctura SA, Geneva, Switzerland;","institution_ids":["https://openalex.org/I4405267753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082767891","display_name":"Amy Fraser","orcid":"https://orcid.org/0009-0007-4883-7538","observed_orcids":["https://orcid.org/0009-0007-4883-7538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy Fraser","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091158700","display_name":"Lars van der Veen","orcid":"https://orcid.org/0000-0003-4525-0081","observed_orcids":["https://orcid.org/0000-0003-4525-0081"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lars van der Veen","raw_affiliation_strings":["4iOnctura SA, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4iOnctura SA, Amsterdam, Netherlands;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108685103","display_name":"Pritom Shah","orcid":"https://orcid.org/0000-0002-1202-3336","observed_orcids":["https://orcid.org/0000-0002-1202-3336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pritom Shah","raw_affiliation_strings":["2CRUK, Cambridge, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CRUK, Cambridge, United Kingdom;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040259819","display_name":"Luigi Ziviani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luigi ZIviani","raw_affiliation_strings":["5Centro Ricerche Cliniche di Verona S.r.l., Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Centro Ricerche Cliniche di Verona S.r.l., Verona, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012765772","display_name":"Stefano Milleri","orcid":"https://orcid.org/0000-0001-7459-7434","observed_orcids":["https://orcid.org/0000-0001-7459-7434"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefano Milleri","raw_affiliation_strings":["5Centro Ricerche Cliniche di Verona S.r.l., Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Centro Ricerche Cliniche di Verona S.r.l., Verona, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033549340","display_name":"Michael Lahn","orcid":"https://orcid.org/0000-0002-1377-7308","observed_orcids":["https://orcid.org/0000-0002-1377-7308"]},"institutions":[{"id":"https://openalex.org/I4405267753","display_name":"iOnctura SA (Switzerland)","ror":"https://ror.org/046dw9c33","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267753"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Lahn","raw_affiliation_strings":["1iOnctura SA, Geneva, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1iOnctura SA, Geneva, Switzerland;","institution_ids":["https://openalex.org/I4405267753"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"2636","last_page":"2636"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/autotaxin","display_name":"autotaxin","score":0.9350000023841858},{"id":"https://openalex.org/keywords/lysophosphatidic-acid","display_name":"lysophosphatidic acid","score":0.9769999980926514},{"id":"https://openalex.org/keywords/lysophosphatidylcholine","display_name":"lysophosphatidylcholine","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7739999890327454},{"id":"https://openalex.org/keywords/tumor-stroma","display_name":"tumor stroma","score":0.7170000076293945},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.7549999952316284},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.828000009059906},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6830000281333923},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.8029999732971191},{"id":"https://openalex.org/keywords/ca19-9","display_name":"CA19-9","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C37547375","wikidata":"https://www.wikidata.org/wiki/Q14913997","display_name":"Autotaxin","level":4,"score":0.8627861738204956},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7574857473373413},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.7281755805015564},{"id":"https://openalex.org/C2776661833","wikidata":"https://www.wikidata.org/wiki/Q2823281","display_name":"Lysophosphatidic acid","level":3,"score":0.6957395076751709},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6268523335456848},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5218671560287476},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4391426742076874},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41961753368377686},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33244752883911133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32901453971862793},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2885912358760834},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20358875393867493}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-2636","doi":"https://doi.org/10.1158/1538-7445.am2022-2636","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-2636","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3214617046","https://openalex.org/W4410219770","https://openalex.org/W6944185464","https://openalex.org/W3005361124","https://openalex.org/W2109710025","https://openalex.org/W2976358175","https://openalex.org/W2581419557","https://openalex.org/W4386317034","https://openalex.org/W4392888885","https://openalex.org/W2791993094"],"abstract_inverted_index":{"Abstract":[0],"Recent":[1],"findings":[2],"indicate":[3],"that":[4,55,64,75,177,256,285],"in":[5,24,53,79,121,131,142,161,162,174,210,222,225,244,250,260,342,387,396],"cancer,":[6],"host":[7],"immune":[8,49],"suppression":[9],"and":[10,19,48,95,109,124,195,224,246,272,324],"resistance":[11,35],"to":[12,31,36,42,46,68,86,199,267,335,383,391,394],"therapy":[13,37,395],"is":[14,61,76,104,333],"orchestrated":[15],"by":[16],"the":[17,25,44,169,179,183,189,214,288,326,388,404],"presence":[18],"activity":[20,205],"of":[21,113,139,154,166,182,191,193,213,217,287,311,403],"stromal":[22,33,180,385],"cells":[23],"tumor":[26,90,304,389,398],"microenvironment.":[27,184],"Therefore":[28],"novel":[29],"approaches":[30],"overcome":[32],"mediated":[34],"represent":[38],"a":[39,57,72,105,115,126,143,228,233,240,247,295,337],"potential":[40],"strategy":[41,298],"improve":[43,392],"outcome":[45,393],"chemotherapy":[47],"checkpoint":[50],"blockade,":[51],"particularly":[52],"tumors":[54],"have":[56],"fibrotic":[58,122,303,397],"microenviroment.":[59],"Autotaxin":[60,382],"an":[62],"enzyme":[63],"converts":[65],"Lysophosphatidylcholine":[66],"(LPC)":[67],"Lysophosphatidic":[69],"Acid":[70],"(LPA),":[71],"key":[73],"pathway":[74,290],"aberrantly":[77],"activated":[78],"fibrosis.":[80],"LPA":[81,100,141],"has":[82,313],"also":[83,254],"been":[84,314],"described":[85],"act":[87],"directly":[88],"on":[89,206,279],"cells,":[91],"promoting":[92],"their":[93],"growth":[94],"proliferation":[96],"via":[97],"G":[98],"protein-coupled":[99],"Receptors":[101],"(LPARs).":[102],"IOA-289":[103,136,157,238,292,312,332],"novel,":[106],"potent,":[107],"selective":[108],"orally":[110],"bioavailable":[111],"inhibitor":[112],"Autotaxin,":[114],"target":[116],"with":[117,125,275,291,302],"known":[118],"clinical":[119,340],"application":[120],"diseases":[123],"strong":[127],"rationale":[128],"for":[129,299,407],"exploration":[130],"cancer.":[132,167,344],"In":[133,185,227],"preclinical":[134,281,322],"models,":[135],"modulated":[137],"levels":[138],"circulating":[140,155,251],"dose":[144,241,310],"dependent":[145,242],"manner.":[146],"At":[147],"doses":[148],"achieving":[149],"at":[150],"least":[151],"50%":[152],"reduction":[153],"LPA,":[156],"showed":[158,239],"monotherapeutic":[159],"efficacy":[160],"vivo":[163,226],"mouse":[164],"models":[165,176],"Notably":[168],"effects":[170],"were":[171],"most":[172],"prominent":[173],"orthotopic":[175],"recapitulate":[178],"components":[181],"vitro":[186,211,223],"studies":[187,323],"investigated":[188],"mechanism":[190],"action":[192],"IOA-289,":[194],"it":[196],"was":[197,258],"shown":[198],"be":[200,294],"driven":[201],"by:":[202],"(i)Direct":[203],"anti-tumor":[204],"cancer":[207,264,300],"cell":[208,220],"lines":[209],"(ii)Modulation":[212],"secretory":[215],"profile":[216],"fibroblasts(iii)Increased":[218],"T":[219],"infiltration":[221],"healthy":[229,270,329],"volunteer":[230,330],"study":[231],"following":[232],"single":[234],"oral":[235],"ascending":[236],"dose,":[237],"increase":[243],"plasma":[245,261],"corresponding":[248],"decrease":[249],"LPA.":[252],"We":[253],"demonstrated":[255],"ATX":[257],"elevated":[259],"from":[262,269,321,325],"pancreatic":[263,343],"patients":[265,301],"compared":[266],"samples":[268],"volunteers":[271],"are":[273],"correlated":[274],"soluble":[276],"CA19-9.":[277],"Based":[278],"our":[280],"data":[282,320],"we":[283],"postulate":[284],"inhibition":[286],"ATX/LPA":[289],"may":[293],"beneficial":[296],"therapeutic":[297],"microenvironments.":[305],"The":[306],"predicted":[307],"biologically":[308],"effective":[309],"calculated":[315],"using":[316],"PK/PD":[317],"modelling":[318],"combining":[319],"phase":[327,338],"Ia":[328],"study.":[331],"scheduled":[334],"enter":[336],"Ib":[339],"trial":[341],"Citation":[345],"Format:":[346],"Zoe":[347],"Johnson,":[348],"Marcel":[349],"Deken,":[350],"Ragini":[351],"Medhi,":[352],"Lauren":[353],"Maggs,":[354],"Alan":[355],"Carruthers,":[356],"Anne":[357],"Cheasty,":[358],"Alessia":[359],"Tagliavini,":[360],"Andrea":[361],"Nizzardo,":[362],"Marco":[363],"Pergher,":[364],"Karolina":[365],"Niewola,":[366],"Amy":[367],"Fraser,":[368],"Lars":[369],"van":[370],"der":[371],"Veen,":[372],"Pritom":[373],"Shah,":[374],"Luigi":[375],"ZIviani,":[376],"Stefano":[377],"Milleri,":[378],"Michael":[379],"Lahn.":[380],"Targeting":[381],"suppress":[384],"signaling":[386],"microenvironment":[390],"types":[399],"[abstract].":[400],"In:":[401],"Proceedings":[402],"American":[405],"Association":[406],"Cancer":[408,419],"Research":[409],"Annual":[410],"Meeting":[411],"2022;":[412],"2022":[413],"Apr":[414],"8-13.":[415],"Philadelphia":[416],"(PA):":[417],"AACR;":[418],"Res":[420],"2022;82(12_Suppl):Abstract":[421],"nr":[422],"2636.":[423]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2022-06-17T00:00:00"}